Catalyst Pharmaceuticals Inc (CPRX)
16.49
+0.09
(+0.55%)
USD |
NASDAQ |
May 17, 16:00
16.74
+0.25
(+1.52%)
After-Hours: 20:00
Catalyst Pharmaceuticals Revenue (TTM): 411.35M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 411.35M |
| December 31, 2023 | 398.20M |
| September 30, 2023 | 348.39M |
| June 30, 2023 | 302.95M |
| March 31, 2023 | 256.48M |
| December 31, 2022 | 214.20M |
| September 30, 2022 | 191.76M |
| June 30, 2022 | 170.46M |
| March 31, 2022 | 153.72M |
| December 31, 2021 | 140.83M |
| Date | Value |
|---|---|
| September 30, 2021 | 133.54M |
| June 30, 2021 | 126.90M |
| March 31, 2021 | 120.14M |
| December 31, 2020 | 119.07M |
| September 30, 2020 | 118.18M |
| June 30, 2020 | 119.76M |
| March 31, 2020 | 118.99M |
| December 31, 2019 | 102.31M |
| September 30, 2019 | 72.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
72.68M
Minimum
Sep 2019
411.35M
Maximum
Mar 2024
190.52M
Average
140.83M
Median
Dec 2021
Revenue (TTM) Benchmarks
| Pfizer Inc | 55.09B |
| Sarepta Therapeutics Inc | 1.403B |
| PTC Therapeutics Inc | 927.56M |
| Corcept Therapeutics Inc | 523.53M |
| Cytokinetics Inc | 3.752M |